• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估临床慢性阻塞性肺疾病问卷:系统评价。

Evaluating the Clinical COPD Questionnaire: A systematic review.

机构信息

Department of Respiratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

Respirology. 2017 Feb;22(2):251-262. doi: 10.1111/resp.12970.

DOI:10.1111/resp.12970
PMID:28102972
Abstract

The Clinical COPD Questionnaire (CCQ) is recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to evaluate health status in patients with COPD. The objective of this work was to systemically assess the reliability, validity, responsiveness and minimum clinically important difference (MCID) of the CCQ. A structured search was conducted in three databases to identify articles that evaluated the psychometric properties of the CCQ in individuals with COPD. Two investigators screened the title, abstract and full text of the articles to determine study eligibility and performed the data extraction. Quality assessment of included studies was assessed by the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) checklist. Finally, 43 studies were included, over half of which had fair methodological quality. Internal consistency (reliability) of the CCQ total score ranged from 0.84 to 0.94, and test-retest reliability was 0.70-0.99. The overall CCQ had a better correlation with St George's Respiratory Questionnaire (SGRQ; from 0.71 to 0.88) and COPD Assessment Test (CAT; from 0.64 to 0.88) than modified Medical Research Council (mMRC; from 0.392 to 0.668) and forced expiratory volume in 1 s (FEV % predicted; from -0.31 to -0.68). Scores were different within GOLD stages, groups, composite events and co-morbidities. CCQ was sensitive to exacerbations, pulmonary rehabilitation and smoking cessation with the MCID of 0.4. The CCQ is a very useful and practical tool that can be used in clinical populations with good reliability, validity and responsiveness to interventions.

摘要

慢性阻塞性肺疾病临床问卷(CCQ)被全球慢性阻塞性肺疾病倡议(GOLD)推荐用于评估 COPD 患者的健康状况。本研究旨在系统评估 CCQ 的可靠性、有效性、反应性和最小临床重要差异(MCID)。在三个数据库中进行了结构化搜索,以确定评估 COPD 患者 CCQ 心理测量特性的文章。两名调查员筛选了文章的标题、摘要和全文,以确定研究的合格性,并进行了数据提取。采用共识基础健康测量仪器选择标准(COSMIN)检查表评估纳入研究的质量。最终纳入了 43 项研究,其中超过一半的研究方法质量中等。CCQ 总分的内部一致性(可靠性)范围为 0.84 至 0.94,重测信度为 0.70-0.99。总体而言,CCQ 与圣乔治呼吸问卷(SGRQ;0.71 至 0.88)和 COPD 评估测试(CAT;0.64 至 0.88)的相关性优于改良医学研究委员会(mMRC;0.392 至 0.668)和 1 秒用力呼气量(FEV %预测;-0.31 至 -0.68)。在 GOLD 分期、组别、综合事件和合并症中,评分存在差异。CCQ 对加重、肺康复和戒烟敏感,MCID 为 0.4。CCQ 是一种非常有用和实用的工具,可用于具有良好可靠性、有效性和对干预措施反应性的临床人群。

相似文献

1
Evaluating the Clinical COPD Questionnaire: A systematic review.评估临床慢性阻塞性肺疾病问卷:系统评价。
Respirology. 2017 Feb;22(2):251-262. doi: 10.1111/resp.12970.
2
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
3
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
4
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
5
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
6
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
7
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
8
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
9
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).长效毒蕈碱拮抗剂(LAMA)联合长效β受体激动剂(LABA)与LABA联合吸入性糖皮质激素(ICS)用于稳定期慢性阻塞性肺疾病(COPD)的比较
Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD012066. doi: 10.1002/14651858.CD012066.pub2.
10
Pulmonary rehabilitation versus usual care for adults with asthma.肺康复治疗与常规护理对哮喘成人的影响比较。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013485. doi: 10.1002/14651858.CD013485.pub2.

引用本文的文献

1
Combined Effect of 12 Weeks Baduanjin and Tri-Ball Respiratory Training as a Home-Based Pulmonary Rehabilitation in Subjects With Moderate Chronic Obstructive Pulmonary Disease: A Multi-Center Randomized Controlled Trial.为期12周的八段锦与三球呼吸训练联合作为中度慢性阻塞性肺疾病患者家庭肺康复的综合效果:一项多中心随机对照试验
Rehabil Nurs. 2025 May 1;50(2):78-87. doi: 10.1097/RNJ.0000000000000493. Epub 2025 Apr 4.
2
Population-based Screening for Chronic Obstructive Pulmonary Disease Using the St. George's Respiratory Questionnaire in Resource-limited Settings.在资源有限的环境中使用圣乔治呼吸问卷对慢性阻塞性肺疾病进行基于人群的筛查。
Am J Respir Crit Care Med. 2025 Mar 11;211(5):779-88. doi: 10.1164/rccm.202409-1862OC.
3
Associations of Vitamin D With GPX4 and Iron Parameters in Chronic Obstructive Pulmonary Disease Patients: A Case-Control Study.
维生素 D 与慢性阻塞性肺疾病患者 GPX4 和铁参数的相关性:一项病例对照研究。
Can Respir J. 2024 Oct 28;2024:4505905. doi: 10.1155/2024/4505905. eCollection 2024.
4
Diagnostic value of CT in patients with stable chronic obstructive pulmonary disease at high altitude: Observational study.CT 对高海拔稳定期慢性阻塞性肺疾病患者的诊断价值:观察性研究。
Medicine (Baltimore). 2024 Nov 1;103(44):e40291. doi: 10.1097/MD.0000000000040291.
5
Predictive Value of CCQ and its Subdomains for Hospitalized Exacerbations in Chronic Obstructive Pulmonary Disease: A 3-Year Observational Prospective Study.慢性阻塞性肺疾病患者住院急性加重期CCQ及其子领域的预测价值:一项为期3年的观察性前瞻性研究。
J Gen Intern Med. 2025 May;40(7):1550-1558. doi: 10.1007/s11606-024-09067-0. Epub 2024 Oct 1.
6
Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial.肺康复对慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停患者的疗效:一项随机对照试验。
J Rehabil Med. 2024 Sep 24;56:jrm23757. doi: 10.2340/jrm.v56.23757.
7
Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者低衰减区评分与肺功能及临床预后的相关性
Open Life Sci. 2024 Aug 14;19(1):20220871. doi: 10.1515/biol-2022-0871. eCollection 2024.
8
A double-blind randomized controlled trial of N-acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease.一项关于N-乙酰半胱氨酸(NAC)治疗慢性阻塞性肺疾病急性加重期的双盲随机对照试验。
Respirol Case Rep. 2024 Aug 6;12(8):e01449. doi: 10.1002/rcr2.1449. eCollection 2024 Aug.
9
Evaluation of Telemedicine Consultations Using Health Outcomes and User Attitudes and Experiences: Scoping Review.使用健康结果和用户态度与体验评估远程医疗咨询:范围综述。
J Med Internet Res. 2024 Jul 9;26:e53266. doi: 10.2196/53266.
10
Nurse and Social Worker Palliative Telecare Team and Quality of Life in Patients With COPD, Heart Failure, or Interstitial Lung Disease: The ADAPT Randomized Clinical Trial.护士和社会工作者姑息治疗远程护理团队与 COPD、心力衰竭或间质性肺病患者的生活质量:ADAPT 随机临床试验。
JAMA. 2024 Jan 16;331(3):212-223. doi: 10.1001/jama.2023.24035.